Advocacy intelligence hub — real-time data for patient organizations
Phos-Lo: FDA approved
Treatment of hyperphosphatemia in end stage renal failure.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Phos-Lo
Fresenius Medical Care North America
Browse all Hyperphosphatasia-intellectual disability syndrome news →
View all Hyperphosphatasia-intellectual disability syndrome specialists →